ArticleCancers2026

Body Mass Index and Outcomes in HR+/HER2- Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study.

Larisa Maria Badau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.